The effects of food on the bioavailability of a sustained‐release (SR) formulation of verapamil (SR‐verapamil; Isoptin SR) were determined in an open, three‐way single‐dose study involving 12 volunteers receiving (in randomized order) the SR preparation (1 × 240 mg) either fasting or with food and a conventional formulation of verapamil (3 × 80 mg) fasting. Compared with the conventional formulation, SR‐verapamil had a reduced Cmax, prolonged tmax, and unchanged t1/2, consistent with its SR formulation. The AUC was 80% of the conventional preparation. Concomitant food administration significantly prolonged the tmax of SR‐verapamil from 7.3 ± 3.4 to 11.7 ± 6.3 h, but had little effect on Cmax, t1/2, or AUC. Similar results were obtained with the metabolite, norverapamil. Food administration also had little effect on the blood pressure and ECG effects of SR‐verapamil. Cautions regarding taking this preparation with food therefore appear to be unnecessary.